Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

YM 022

Name YM 022
Supplier R&D Systems
Catalog 1408
Prices $189.00, $765.00
Sizes 10 mg, 50 mg
Cas Number 145084-28-2
Chemical Name (R)-N-[2,3-Dihydro-1-[2-(2-methylphenyl)-2-oxoethyl]-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)-urea
Formula C32H28N4O3
Molecular Weight 516.6
Purity >99%
Supplier Page Shop

Product References

Cholecystokinin inhibits inducible nitric oxide synthase expression by - Cholecystokinin inhibits inducible nitric oxide synthase expression by

Saia RS, Mestriner FL, Bertozi G, Cunha FQ, Carnio EC. Mediators Inflamm. 2014;2014:896029.

The dorsomedial hypothalamus mediates stress-induced hyperalgesia and is the - The dorsomedial hypothalamus mediates stress-induced hyperalgesia and is the

Wagner KM, Roeder Z, Desrochers K, Buhler AV, Heinricher MM, Cleary DR. Neuroscience. 2013 May 15;238:29-38.

Activation of descending pain-facilitatory pathways from the rostral ventromedial - Activation of descending pain-facilitatory pathways from the rostral ventromedial

Marshall TM, Herman DS, Largent-Milnes TM, Badghisi H, Zuber K, Holt SC, Lai J, Porreca F, Vanderah TW. Pain. 2012 Jan;153(1):86-94.

Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and - Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and

Karson MA, Whittington KC, Alger BE. Neuropharmacology. 2008 Jan;54(1):117-28. Epub 2007 Jul 1.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved